| Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor M Galli, T Barbui, P Comfurius, C Maassen, HC Hemker, RFA Zwaal, ... The Lancet 335 (8705), 1544-1547, 1990 | 1764 | 1990 |
| Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange M Van Der Neut Kolfschoten, J Schuurman, M Losen, WK Bleeker, ... Science 317 (5844), 1554-1557, 2007 | 1120 | 2007 |
| Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind … JF Howard, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, ... The Lancet Neurology 16 (12), 976-986, 2017 | 585 | 2017 |
| Inflammation, depressive symptomatology, and coronary artery disease AD Appels, FW Bär, J Bär, C Bruggeman, M de Baets Psychosomatic Medicine 62 (5), 601-605, 2000 | 416 | 2000 |
| An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis DB Sanders, IK Hart, R Mantegazza, SS Shukla, ZA Siddiqi, ... Neurology 71 (6), 400-406, 2008 | 305 | 2008 |
| Small fiber neuropathy: a common and important clinical disorder E Hoitsma, JPH Reulen, M De Baets, M Drent, F Spaans, CG Faber Journal of the neurological sciences 227 (1), 119-130, 2004 | 275 | 2004 |
| Intraepidermal nerve fiber density and its application in sarcoidosis M Bakkers, ISJ Merkies, G Lauria, G Devigili, P Penza, R Lombardi, ... Neurology 73 (14), 1142-1148, 2009 | 269 | 2009 |
| Small fibre neuropathy in sarcoidosis E Hoitsma, M Marziniak, CG Faber, JPH Reulen, C Sommer, M De Baets, ... The Lancet 359 (9323), 2085-2086, 2002 | 261 | 2002 |
| Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice R Klooster, JJ Plomp, MG Huijbers, EH Niks, KR Straasheijm, FJ Detmers, ... Brain 135 (4), 1081-1101, 2012 | 225 | 2012 |
| The features of myasthenia gravis with autoantibodies to MuSK D Lavrnic, M Losen, A Vujic, M De Baets, LJ Hajdukovic, V Stojanovic, ... Journal of Neurology, Neurosurgery & Psychiatry 76 (8), 1099-1102, 2005 | 201 | 2005 |
| The lipid droplet coat protein perilipin 5 also localizes to muscle mitochondria M Bosma, R Minnaard, LM Sparks, G Schaart, M Losen, MH De Baets, ... Histochemistry and cell biology 137, 205-216, 2012 | 191 | 2012 |
| Perilipin 2 improves insulin sensitivity in skeletal muscle despite elevated intramuscular lipid levels M Bosma, MKC Hesselink, LM Sparks, S Timmers, MJ Ferraz, F Mattijssen, ... Diabetes 61 (11), 2679-2690, 2012 | 185 | 2012 |
| Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4 JJGM Verschuuren, MG Huijbers, JJ Plomp, EH Niks, PC Molenaar, ... Autoimmunity reviews 12 (9), 918-923, 2013 | 181 | 2013 |
| Antiphospholipid syndrome: diagnostic aspects of lupus anticoagulants J Arnout Thrombosis and haemostasis 86 (07), 83-91, 2001 | 181 | 2001 |
| Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant … YF Graus, MH De Baets, PW Parren, S Berrih-Aknin, J Wokke, ... Journal of immunology (Baltimore, Md.: 1950) 158 (4), 1919-1929, 1997 | 168 | 1997 |
| Strong association of MuSK antibody–positive myasthenia gravis and HLA-DR14-DQ5 EH Niks, JBM Kuks, BO Roep, GW Haasnoot, W Verduijn, B Ballieux, ... Neurology 66 (11), 1772-1774, 2006 | 151 | 2006 |
| Inter-laboratory variability of anti-β2-glycoprotein I measurement G Reber, I Schousboe, A Tincani, M Sanmarco, T Kveder, P de Moerloose, ... Thrombosis and haemostasis 88 (07), 66-73, 2002 | 151 | 2002 |
| Antibody effector mechanisms in myasthenia gravis—pathogenesis at the neuromuscular junction AM Gomez, J Van Den Broeck, K Vrolix, SP Janssen, MAM Lemmens, ... Autoimmunity 43 (5-6), 353-370, 2010 | 148 | 2010 |
| Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis AM Gomez, K Vrolix, P Martínez-Martínez, PC Molenaar, M Phernambucq, ... The Journal of Immunology 186 (4), 2503-2513, 2011 | 145 | 2011 |
| Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy O Stuve, PD Cravens, EM Frohman, JT Phillips, GM Remington, ... Neurology 72 (5), 396-401, 2009 | 142 | 2009 |
